Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
34%
ALSO IN CANC
CANC
54
HOLDINGS
25%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ASTRAZENECA PLC | 4.8% | 4.6% | 4.6% |
 |
ELI LILLY & CO | 10.0% | 4.3% | 4.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.5% | 4.1% | 4.1% |
|
MERCK & CO. INC. | 4.2% | 3.8% | 3.8% |
|
NOVARTIS AG | 3.6% | 4.9% | 3.6% |
HRTS Overweight Relative to CANC
|
ELI LILLY & CO | 5.7% |
|
THERMO FISHER SCIENTIFIC INC | 4.0% |
|
UNITEDHEALTH GROUP INC | 3.8% |
|
ABBOTT LABORATORIES | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
|
DANAHER CORP | 2.9% |
|
GILEAD SCIENCES INC | 2.8% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
 |
MEDTRONIC PLC | 2.4% |
|
JOHNSON & JOHNSON | 2.3% |
HRTS Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -4.1% |
|
ARCELLX, INC. | -3.4% |
|
COGENT BIOSCIENCES INC | -3.3% |
|
NUVALENT, INC. CLASS A | -3.1% |
 |
GENMAB A/S SPONSORED ADR | -3.1% |
|
IMMUNOME, INC. | -2.7% |
|
BRIDGEBIO PHARMA, INC. | -2.5% |
|
CELCUITY INC. | -2.5% |
|
EXELIXIS INC | -2.2% |
|
BRISTOL-MYERS SQUIBB CO | -2.1% |